Target Als Foundation Inc is a 501(c)(3) organization based in New York, New York, registered in 2020, with $33,261,985 in FY2025 revenue. CharityIndex grades it A, and it directs about 82% of spending to programs.
Revenue (FY2025)
$33.3M
▼ 35.7% vs prior year
Education median: $200K
Expenses (FY2025)
$25.6M
Net assets
$135.1M
Employees
18
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Target Als Foundation Inc: 82% to programs · $6 to raise $100 earns a A on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Target Als Foundation Inc: 63 mo reserves · +23% margin earns a B+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Target Als Foundation Inc: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Target Als Foundation Inc: 4 of 5 disclosure signals earns a A on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Our mission is to break down barriers to als research to find effective treatments. by uniting academia, the pharma and biotech industry, government, venture capital, related nonprofits, and the als community, we aim to overcome the challenges that have long hindered progress, bringing hope and tangible advancements to those affected by this devastating disease.
Revenue grew from $5.5M (FY2019) to $33.3M (FY2025) across 7 reported years.
Financial snapshot
Operating margin
23.0%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$136.9M
Total liabilities
$1.9M
Net assets
$135.1M
Salaries & benefits
$3.9M
15% of expenses
Board members
14
14 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2025 | $33,261,985▼35.7% | $25,618,714▼5.5% | $135,059,017▲8.4% | $136,912,637▲6.2% | 990 |
| 2024 | $51,745,776▼35.0% | $27,108,058▲70.9% | $124,560,087▼29.8% | $128,911,762▼28.6% | 990PF |
| 2023 | $79,570,641▼19.1% | $15,859,537▲71.0% | $177,524,182▲56.0% | $180,572,961▲56.3% | 990PF |
| 2022 | $98,381,069▲1310% | $9,271,989▲19.0% | $113,813,078▲355% | $115,562,468▲336% | 990PF |
| 2021 | $6,977,665▼74.4% | $7,789,597▲11.2% | $25,025,662▼3.1% | $26,527,264▼1.8% | 990PF |
| 2020 | $27,270,423▲397% | $7,004,450▲28.2% | $25,837,594▲366% | $27,026,641▲369% | 990PF |
| 2019 | $5,489,621 | $5,462,803 | $5,542,887 | $5,760,183 | 990PF |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Manish Raisinghani — $404,414 (1.58% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Manish Raisinghani | President | 40 | $404,414 |
| Amy Easton | Vice President, Research Groups | 40 | $299,898 |
| Kenneth Devaney | Chief Operating Officer | 40 | $293,699 |
| Jessica Chapman | Chief Development Officer | 40 | $240,468 |
| Yuliya Rzad | Chief Grants Officer | 40 | $206,142 |
| Laura Dugom | Associate Director Clinical Research | 40 | $168,857 |
| Stephanie Ishoo | Director of Marketing & Communications | 40 | $165,555 |
| Christine Prouty Aranyos | Director of Philanthropy | 40 | $165,242 |
| Alisa Doctoroff | Board Member | 1 | — |
| Allison Jaffin | Board Member | 1 | — |
| Andy Berndt | Board Member | 1 | — |
| Brad S Karp | Board Member | 1 | — |
| Carol Ho | Board Member | 1 | — |
| Chris Hernderson | Board Member | 1 | — |
| Daniel L Doctoroff | Board Chair | 1 | — |
| Eric Dane | Board Member (as of 12/25) | 1 | — |
| John Dunlop | Board Member | 1 | — |
| Richard Hargreaves | Board Member | 1 | — |
| Sarah Sheikh | Board Member | 1 | — |
| Stacy Weninger | Board Member | 1 | — |
51 grants to Target Als Foundation Inc totaling $71.3M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Jewish Communal Fund | In furtherance of grantee's tax-exempt purpose | 2024 | $10,516,458 |
| National Football League Foundation | General support | 2024 | $250,000 |
| The New York Community Trust | For general support. | 2024 | $200,000 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $45,000 |
| American Online Giving Foundation Inc | General support | 2024 | $36,026 |
| Tides Foundation | Healthy individuals and communities | 2024 | $25,000 |
| T Rowe Price Program For Charitable Giving Inc | Multiple | 2024 | $15,500 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $8,750 |
| Jewish Communal Fund | In furtherance of grantee's tax-exempt purpose | 2023 | $10,446,860 |
| Donor Advised Charitable Giving | Health | 2023 | $711,800 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $621,200 |
| Vanguard Charitable Endowment Program | For recipient's exempt purpose | 2023 | $426,000 |
| National Football League Foundation | General support | 2023 | $250,000 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2023 | $240,000 |
| National Philanthropic Tr | Health | 2023 | $231,756 |
47 grants totaling $10.1M in FY2025 — showing the 15 largest. All grants made by Target Als Foundation Inc →
| Recipient | Purpose | Amount |
|---|---|---|
| Dignity Health | Scientific research | $800,313 |
| University of California San Francisco | Scientific research | $731,472 |
| Mayo Clinic | Scientific research | $579,510 |
| Columbia University Health Care Inc | Scientific research | $575,116 |
| Regents of the University of California At San Diego | Scientific research | $461,402 |
| Northwestern University | Scientific research | $438,968 |
| Emory University | Scientific research | $386,594 |
| Mass General Brigham Incorporated | Scientific research | $375,000 |
| The University of Alabama At Birmingham | Scientific research | $298,217 |
| University of California Santa Barbara | Scientific research | $290,000 |
| University of Southern California | Scientific research | $260,000 |
| Regents of the University of Michigan | Scientific research | $255,000 |
| Johns Hopkins University | Scientific research | $253,263 |
| Washington University | Scientific research | $213,046 |
| Trustees of the University of Pennsylvania | Scientific research | $210,429 |
Explore more
Data for Target Als Foundation Inc (EIN 81-0756743) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.